<html lang="en">
<head>
<meta charset="utf-8"/>
<title offset="950">IC50</title>
<script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_SVG.js" type="text/javascript">
</script>
</head>
<body>
<h1>IC50</h1>
<hr/>
<figure><b>(Figure)</b>
<figcaption>Visual demonstration of how to derive IC50 value: Arrange data with inhibition on vertical axis and log(concentration) on horizontal axis; then identify max and min inhibition; then the IC50 is the concentration at which the curve passes through the 50% inhibition level.</figcaption>
</figure>

<p>The <strong>half maximal inhibitory concentration (IC<sub>50</sub>)</strong> is a measure of the effectiveness of a substance in inhibiting a specific biological or biochemical function.</p>

<p>This quantitative measure indicates how much of a particular drug or other substance (<a href="Enzyme_inhibitor" title="wikilink">inhibitor</a>) is needed to inhibit a given biological process (or component of a process, i.e. an <a class="uri" href="enzyme" title="wikilink">enzyme</a>, <a href="cell_(biology)" title="wikilink">cell</a>, <a href="cell_receptor" title="wikilink">cell receptor</a> or <a class="uri" href="microorganism" title="wikilink">microorganism</a>) by half. It is commonly used as a measure of <a href="Receptor_antagonists" title="wikilink">antagonist drug</a> <a href="potency_(pharmacology)" title="wikilink">potency</a> in pharmacological research. According to the <a href="Food_and_Drug_Administration" title="wikilink">FDA</a>, IC<sub>50</sub> represents the concentration of a drug that is required for 50% inhibition <em><a href="in_vitro" title="wikilink">in vitro</a></em>.<a class="footnoteRef" href="#fn1" id="fnref1"><sup>1</sup></a> It is comparable to an <a href="half_maximal_effective_concentration" title="wikilink">EC<sub>50</sub></a> for <a href="agonist" title="wikilink">agonist drugs</a>. EC<sub>50</sub> also represents the plasma concentration required for obtaining 50% of a maximum effect <em><a href="in_vivo" title="wikilink">in vivo</a></em>.<a class="footnoteRef" href="#fn2" id="fnref2"><sup>2</sup></a></p>
<h2 id="determining-the-ic50-of-a-drug">Determining the IC<sub>50</sub> of a drug</h2>
<h3 id="functional-antagonist-assay">Functional antagonist assay</h3>

<p>The IC<sub>50</sub> of a drug can be determined by constructing a <a href="Dose-response_relationship" title="wikilink">dose-response curve</a> and examining the effect of different concentrations of antagonist on reversing agonist activity. IC<sub>50</sub> values can be calculated for a given antagonist by determining the concentration needed to inhibit half of the maximum biological response of the agonist.<a class="footnoteRef" href="#fn3" id="fnref3"><sup>3</sup></a></p>

<p>IC<sub>50</sub> values are very dependent on conditions under which they are measured. In general, the higher the concentration of inhibitor, the more agonist activity will be lowered. IC<sub>50</sub> value increases as agonist concentration increases. Furthermore depending on the type of inhibition other factors may influence IC<sub>50</sub> value; for <a href="Adenosine_triphosphate" title="wikilink">ATP</a> dependent enzymes IC<sub>50</sub> value has an interdependency with concentration of ATP, especially so if inhibition is all of it <a href="Competitive_inhibition" title="wikilink">competitive</a>. IC<sub>50</sub> values can be used to compare the potency of two antagonists.</p>
<h3 id="competition-binding-assays">Competition binding assays</h3>

<p>In this type of assay, a single concentration of radioligand (usually an agonist) is used in every assay tube. The ligand is used at a low concentration, usually at or below its <a href="dissociation_constant" title="wikilink">K<sub>d</sub></a> value. The level of specific binding of the radioligand is then determined in the presence of a range of concentrations of other competing non-radioactive compounds (usually antagonists), in order to measure the potency with which they compete for the binding of the radioligand. Competition curves may also be computer-fitted to a logistic function as described under direct fit.</p>

<p>In this situation the IC<sub>50</sub> is the concentration of competing ligand which displaces 50% of the specific binding of the radioligand. The IC<sub>50</sub> value is converted to an absolute inhibition constant K<sub>i</sub> using the Cheng-Prusoff equation formulated by Drs. Yung-Chi Cheng and <a href="William_Prusoff" title="wikilink">William Prusoff</a>,(see K<sub>i</sub>).<a class="footnoteRef" href="#fn4" id="fnref4"><sup>4</sup></a><a class="footnoteRef" href="#fn5" id="fnref5"><sup>5</sup></a></p>
<h4 id="ic50-and-affinity">IC<sub>50</sub> and affinity</h4>

<p>IC<sub>50</sub> is not a direct indicator of affinity although the two can be related at least for competitive agonists and antagonists by the Cheng-Prusoff equation.<a class="footnoteRef" href="#fn6" id="fnref6"><sup>6</sup></a> For enzymatic reactions, this equation is:</p>

<p>

<math display="inline" id="IC50:0">
 <semantics>
  <mrow>
   <msub>
    <mi>K</mi>
    <mi>i</mi>
   </msub>
   <mo>=</mo>
   <mfrac>
    <mrow>
     <mi>I</mi>
     <msub>
      <mi>C</mi>
      <mn>50</mn>
     </msub>
    </mrow>
    <mrow>
     <mn>1</mn>
     <mo>+</mo>
     <mfrac>
      <mrow>
       <mo stretchy="false">[</mo>
       <mi>S</mi>
       <mo stretchy="false">]</mo>
      </mrow>
      <msub>
       <mi>K</mi>
       <mi>m</mi>
      </msub>
     </mfrac>
    </mrow>
   </mfrac>
  </mrow>
  <annotation-xml encoding="MathML-Content">
   <apply>
    <eq></eq>
    <apply>
     <csymbol cd="ambiguous">subscript</csymbol>
     <ci>K</ci>
     <ci>i</ci>
    </apply>
    <apply>
     <divide></divide>
     <apply>
      <times></times>
      <ci>I</ci>
      <apply>
       <csymbol cd="ambiguous">subscript</csymbol>
       <ci>C</ci>
       <cn type="integer">50</cn>
      </apply>
     </apply>
     <apply>
      <plus></plus>
      <cn type="integer">1</cn>
      <apply>
       <divide></divide>
       <apply>
        <csymbol cd="latexml">delimited-[]</csymbol>
        <ci>S</ci>
       </apply>
       <apply>
        <csymbol cd="ambiguous">subscript</csymbol>
        <ci>K</ci>
        <ci>m</ci>
       </apply>
      </apply>
     </apply>
    </apply>
   </apply>
  </annotation-xml>
  <annotation encoding="application/x-tex">
   K_{i}=\frac{IC_{50}}{1+\frac{[S]}{K_{m}}}
  </annotation>
 </semantics>
</math>

</p>

<p>where K<sub>i</sub> is the binding affinity of the inhibitor, IC<sub>50</sub> is the functional strength of the inhibitor, [S] is fixed substrate concentration and K<sub>m</sub> is the concentration of substrate at which enzyme activity is at half maximal (but is frequently confused with substrate affinity for the enzyme, which it is not).</p>

<p>Alternatively, for inhibition constants at cellular receptors:<a class="footnoteRef" href="#fn7" id="fnref7"><sup>7</sup></a> 

<math display="inline" id="IC50:1">
 <semantics>
  <mrow>
   <msub>
    <mi>K</mi>
    <mi>i</mi>
   </msub>
   <mo>=</mo>
   <mfrac>
    <mrow>
     <mi>I</mi>
     <msub>
      <mi>C</mi>
      <mn>50</mn>
     </msub>
    </mrow>
    <mrow>
     <mfrac>
      <mrow>
       <mo stretchy="false">[</mo>
       <mi>A</mi>
       <mo stretchy="false">]</mo>
      </mrow>
      <mrow>
       <mi>E</mi>
       <msub>
        <mi>C</mi>
        <mn>50</mn>
       </msub>
      </mrow>
     </mfrac>
     <mo>+</mo>
     <mn>1</mn>
    </mrow>
   </mfrac>
  </mrow>
  <annotation-xml encoding="MathML-Content">
   <apply>
    <eq></eq>
    <apply>
     <csymbol cd="ambiguous">subscript</csymbol>
     <ci>K</ci>
     <ci>i</ci>
    </apply>
    <apply>
     <divide></divide>
     <apply>
      <times></times>
      <ci>I</ci>
      <apply>
       <csymbol cd="ambiguous">subscript</csymbol>
       <ci>C</ci>
       <cn type="integer">50</cn>
      </apply>
     </apply>
     <apply>
      <plus></plus>
      <apply>
       <divide></divide>
       <apply>
        <csymbol cd="latexml">delimited-[]</csymbol>
        <ci>A</ci>
       </apply>
       <apply>
        <times></times>
        <ci>E</ci>
        <apply>
         <csymbol cd="ambiguous">subscript</csymbol>
         <ci>C</ci>
         <cn type="integer">50</cn>
        </apply>
       </apply>
      </apply>
      <cn type="integer">1</cn>
     </apply>
    </apply>
   </apply>
  </annotation-xml>
  <annotation encoding="application/x-tex">
   K_{i}=\frac{IC_{50}}{\frac{[A]}{EC_{50}}+1}
  </annotation>
 </semantics>
</math>

</p>

<p>where [A] is the fixed concentration of agonist and EC<sub>50</sub> is the concentration of agonist that results in half maximal activation of the receptor. Whereas the IC<sub>50</sub> value for a compound may vary between experiments depending on experimental conditions, the K<sub>i</sub> is an absolute value. K<sub>i</sub> is the inhibition constant for a drug; the concentration of competing ligand in a competition assay which would occupy 50% of the receptors if no ligand were present.<a class="footnoteRef" href="#fn8" id="fnref8"><sup>8</sup></a></p>

<p>The Cheng-Prusoff equation produces good estimates at high agonist concentrations, but over- or under-estimates K<sub>i</sub> at low agonist concentrations. In these conditions, other analyses have been recommended.<a class="footnoteRef" href="#fn9" id="fnref9"><sup>9</sup></a></p>
<h3 id="pic50">pIC<sub>50</sub></h3>

<p>Sometimes, IC<sub>50</sub> values are converted to the <strong>pIC<sub>50</sub></strong> scale.</p>

<p>

<math display="inline" id="IC50:2">
 <semantics>
  <mrow>
   <mrow>
    <mi>p</mi>
    <mi>I</mi>
    <msub>
     <mi>C</mi>
     <mn>50</mn>
    </msub>
   </mrow>
   <mo>=</mo>
   <mrow>
    <mo>-</mo>
    <mrow>
     <mi>l</mi>
     <mi>o</mi>
     <msub>
      <mi>g</mi>
      <mn>10</mn>
     </msub>
     <mrow>
      <mo stretchy="false">(</mo>
      <mrow>
       <mi>I</mi>
       <msub>
        <mi>C</mi>
        <mn>50</mn>
       </msub>
      </mrow>
      <mo stretchy="false">)</mo>
     </mrow>
    </mrow>
   </mrow>
  </mrow>
  <annotation-xml encoding="MathML-Content">
   <apply>
    <eq></eq>
    <apply>
     <times></times>
     <ci>p</ci>
     <ci>I</ci>
     <apply>
      <csymbol cd="ambiguous">subscript</csymbol>
      <ci>C</ci>
      <cn type="integer">50</cn>
     </apply>
    </apply>
    <apply>
     <minus></minus>
     <apply>
      <times></times>
      <ci>l</ci>
      <ci>o</ci>
      <apply>
       <csymbol cd="ambiguous">subscript</csymbol>
       <ci>g</ci>
       <cn type="integer">10</cn>
      </apply>
      <apply>
       <times></times>
       <ci>I</ci>
       <apply>
        <csymbol cd="ambiguous">subscript</csymbol>
        <ci>C</ci>
        <cn type="integer">50</cn>
       </apply>
      </apply>
     </apply>
    </apply>
   </apply>
  </annotation-xml>
  <annotation encoding="application/x-tex">
   pIC_{50}=-log_{10}(IC_{50})
  </annotation>
 </semantics>
</math>

</p>

<p>Note the minus sign, which means that higher values of pIC<sub>50</sub> indicate exponentially greater potency.</p>

<p>pIC<sub>50</sub> is usually given in terms of <a href="molar_concentration" title="wikilink">molar concentration</a> (mol/L, or M). Therefore to obtain a pIC<sub>50</sub>, an IC<sub>50</sub> should be specified in units of M. When IC<sub>50</sub> is expressed in μM or nM, it will need to be converted to M before conversion to pIC<sub>50</sub>.<a class="footnoteRef" href="#fn10" id="fnref10"><sup>10</sup></a></p>
<h3 id="behavioral-assays">Behavioral Assays</h3>

<p>The IC<sub>50</sub> terminology is also used for some behavioral measures in vivo, such as a two bottle fluid consumption test. When animals decrease consumption from the drug-laced water bottle, the concentration of the drug that results in a 50% decrease in consumption is considered the IC<sub>50</sub> for fluid consumption of that drug.<a class="footnoteRef" href="#fn11" id="fnref11"><sup>11</sup></a></p>
<h2 id="see-also">See also</h2>
<ul>
<li><a href="Certain_safety_factor" title="wikilink">Certain safety factor</a></li>
<li><a href="EC50" title="wikilink">EC<sub>50</sub></a> (half maximal effective concentration)</li>
<li><a href="LD50" title="wikilink">LD<sub>50</sub></a> (median lethal dose)</li>
</ul>
<h2 id="references">References</h2>
<h2 id="external-links">External links</h2>
<ul>
<li><a href="http://www.ReaderFit.com">ELISA IC50/EC50 Online Tool</a></li>
<li><a href="http://www.sanjeevslab.org/tools.html">IC50 to pIC50 calculator</a></li>
<li><a href="http://www.antimalarial-icestimator.net/">Online tool for analysis of in vitro resistance to antimalarial drugs</a></li>
<li><a href="http://botdb.abcc.ncifcrf.gov/toxin/kiConverter.jsp">IC50-to-Ki converter</a></li>
</ul>

<p>"</p>

<p><a class="uri" href="Category:Pharmacodynamics" title="wikilink">Category:Pharmacodynamics</a></p>
<section class="footnotes">
<hr/>
<ol>
<li id="fn1"><a href="http://www.fda.gov/ohrms/dockets/ac/00/slides/3621s1d/sld036.htm">IC50 versus </a><a class="uri" href="EC50" title="wikilink">EC50</a><a href="#fnref1">↩</a></li>
<li id="fn2"></li>
<li id="fn3"><a href="http://www.ncgc.nih.gov/guidance/section3.html">NIH Chemical Genomics Center // Assay Guidance // Assay Guidance Manual // Assay Operations for SAR Support</a><a href="#fnref3">↩</a></li>
<li id="fn4"></li>
<li id="fn5"><a href="http://www.pdg.cnb.uam.es/cursos/Barcelona2002/pages/Farmac/Comput_Lab/Guia_Glaxo/chap3c.html">Glaxo Wellcome and Science - Global</a><a href="#fnref5">↩</a></li>
<li id="fn6"><a href="#fnref6">↩</a></li>
<li id="fn7"><a href="#fnref7">↩</a></li>
<li id="fn8"></li>
<li id="fn9"></li>
<li id="fn10"><a href="#fnref10">↩</a></li>
<li id="fn11"><a href="#fnref11">↩</a></li>
</ol>
</section>
</body>
</html>
